Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma
Aktuelle Urol. 2017;48(3): 230-237; Breyer J, Otto W, Lausenmeyer EM, Denzinger S, Schwientek AK, Ochs L, Mayr R, Gierth M, Bründl J, Burger M, Evert M, Fritsche HM, Eichelberg C
Management of penile cancer patients: new aspects of a rare tumour entity
Aktuelle Urol. 2017; Roiner M, Maurer O, Lebentrau S, Gilfrich C, Schäfer C, Haberl C, Brookman-May SD, Burger M, May M, Hakenberg OW
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study
BJU Int. 2017; Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group , Bartsch G, Bolenz C, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gilfrich C, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Michel MS, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Traumann M, Vallo S, Wagenlehner FM, Weidner W, Wirth MP, Wullich B
Changes in intraocular pressure and optic nerve sheath diameter in patients undergoing robotic-assisted laparoscopic prostatectomy in steep 45° Trendelenburg position
BMC Anesthesiol. 2017;17(1): 40; Blecha S, Harth M, Schlachetzki F, Zeman F, Blecha C, Flora P, Burger M, Denzinger S, Graf BM, Helbig H, Pawlik MT
Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer
Bladder Cancer. 2017;3(3): 173-180; Breyer J, Shalekenov S, Aziz A, van Rhijn BWG, Bründl J, Lausenmeyer E, Schäfer J, Denzinger S, Giedl C, Burger M, Hartmann A, Evert M, Otto W
Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading?
Bladder Cancer. 2017;3(1): 31-34; Breyer J, Otto W, Burger M, Hartmann A, Rubenwolf PC
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
Cancer Immunol Immunother. 2017; Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, Denzinger S, Burger M, Hartmann A
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians
Clin Genitourin Cancer. 2017;15(3): 356-362; Martini T, Gilfrich C, Mayr R, Burger M, Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J, Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M, Bolenz C
Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
Clin Genitourin Cancer. 2017;15(5): e809-e817; Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A, PROMETRICS 2011 study group , Bartsch G, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Kraischits N, Krausse A, Lusuardi L, Michel MS, Moritz R, Müller SC, Novotny V, Nuhn P, Pahernik S, Palisaar RJ, Ponholzer A, Protzel C, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Vallo S, Wagenlehner FM, Weidner W, Wirth MP
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61
Eur Urol. 2017;71(6): e173-e174; Babjuk M, Burger M, Compérat E, Palou J, Rouprêt M, van Rhijn B, Shariat S, Sylvester R, Zigeuner R, Gontero P, Mostafid H
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Eur Urol. 2017;71(3): 447-461; Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, van Rhijn BW, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Eur Urol. 2017; Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Eur Urol. 2017;72(5): 801-813; Soukup V, Čapoun O, Cohen D, Hernández V, Babjuk M, Burger M, Compérat E, Gontero P, Lam T, MacLennan S, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer
Eur Urol Focus. 2017; Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Gontero P, Lam T, MacLennan S, Mostafid H, Palou J, van Rhijn BWG, Sylvester RJ, Zigeuner R, Shariat SF, Rouprêt M
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review
Eur Urol Focus. 2017; Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, Maclennan S, N'dow J, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Mostafid H, van Rhijn BWG, Gontero P, Palou J, Shariat SF, Roupret M
Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship
Int Urol Nephrol. 2017;49(8): 1311-1318; Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M, MR2 study group , Beiser S, Bernhardt J, Bschleipfer T, Dirik Ö, Geiss J, Hauner K, Hoschke B, Karl T, Kestler A, Klotz T, Kuhl C, Lehsnau M, Macht A, Magistro G, Maurer O, Novotny A, Necknig U, Obermaier R, Promnitz S, Retz M, Scheu C, Scholz C, Stief CG, Truß M
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database
Int Urol Nephrol. 2017;49(2): 247-254; May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P, Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg OW, PROMETRICS 2011 Research Group , Bartsch G, Bolenz C, Buchner A, Chun FK, Durschnabel M, Ellinger J, Fritsche HM, Froehner M, Georgieva G, Gilfrich C, Gördük M, Haferkamp A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Mayr R, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Pycha A, Rink M, Roghmann F, Schmid M, Schramek P, Seitz C, Shariat SF, Sikic D, Stief CG, Syring I, Vallo S, Wagenlehner FM, Wirth MP
WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach
Int Urol Nephrol. 2017;49(3): 431-437;Otto W, Breyer J, Herdegen S, Eder F, Bertz S, May M, Mayr R, Lausenmeyer EM, Denzinger S, van Rhijn BW, Burger M, Hartmann A
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years
J Cancer. 2017;8(3): 323-331; Weyerer V, Schneckenpointner R, Filbeck T, Burger M, Hofstaedter F, Wild PJ, Fine SW, Humphrey PA, Dehner LP, Amin MB, Rüschoff J, Boltze C, Tannapfel A, Zwarthoff E, Lopez-Beltran A, Montironi R, Langner C, Stoehr R, Hartmann A, Giedl J
Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?
J Cancer Educ. 2017;32(1): 135-140; Borgmann H, Wölm JH, Vallo S, Mager R, Huber J, Breyer J, Salem J, Loeb S, Haferkamp A, Tsaur I
Bladder cancer
Nat Rev Dis Primers. 2017;3: 17022; Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
Oncotarget. 2017;8(40): 67684-67695; Breyer J, Wirtz RM, Otto W, Laible M, Schlombs K, Erben P, Kriegmair MC, Stoehr R, Eidt S, Denzinger S, Burger M, Hartmann A
FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
Oncotarget. 2017;8(29): 47595-47606; Rinaldetti S, Wirtz RM, Worst TS, Eckstein M, Weiss CA, Breyer J, Otto W, Bolenz C, Hartmann A, Erben P
Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score
Transl Androl Urol. 2017;6(5): 991-993; Breyer J
High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
Transl Oncol. 2017;10(3): 340-345; Sikic D, Breyer J, Hartmann A, Burger M, Erben P, Denzinger S, Eckstein M, Stöhr R, Wach S, Wullich B, Keck B, Wirtz RM, Otto W
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ
Urol Int. 2017;98(3): 282-289; Breyer J, Otto W, Wirtz RM, Wullich B, Keck B, Erben P, Kriegmair MC, Stoehr R, Eckstein M, Laible M, Schlombs K, Eidt S, Denzinger S, Burger M, Hartmann A, BRIDGE Consortium
Solifenacin in the Elderly: Results of an Observational Study Measuring Efficacy, Tolerability and Cognitive Effects
Urol Int. 2017;98(3): 350-357; Hampel C, Betz D, Burger M, Nowak C, Vogel M
p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models
Urol Oncol. 2017; Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma
Urol Oncol. 2017;35(12): 671.e17-671.e23, Rink M, Engel O, Gakis G, Fritsche HM, Vetterlein MW, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat SF, Fisch M, Gild P
Prerequisites, skills and productivity of young academic urologists in Germany
Urologe A. 2017;56(12): 1603-1610; Borgmann H, Bründl J, Huber J, Ruf C, Schagdarsurgengin U, Wullich B, Salem J
Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?
Urologe A. 2017;56(5): 617-623; Burger M
What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists
Urologe A. 2017; May M, Vetterlein MW, Wagenlehner FM, Brookman-May SD, Gilfrich C, Fritsche HM, Spachmann PJ, Burger M, Schostak M, Lebentrau S, MR2-Studiengruppe
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival
Virchows Arch. 2017;470(3): 267-274; Breyer J, Wirtz RM, Otto W, Erben P, Kriegmair MC, Stoehr R, Eckstein M, Eidt S, Denzinger S, Burger M, Hartmann A, BRIDGE Consortium
The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ)
World J Urol. 2017;35(3): 443-447; Abt D, Dötzer K, Honek P, Müller K, Engeler DS, Burger M, Schmid HP, Knoll T, Sanguedolce F, Joshi HB, Fritsche HM
Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III
World J Urol. 2017;35(5): 737-744; Bach T, Bastian PJ, Blana A, Kaminsky A, Keller S, Knoll T, Lang C, Promnitz S, Ubrig B, Keller T, Qvick B, Burger M, OPTIC III Study Group , Shabayev A, Bick A, Hamza A, Blana A, Secker A, Lorch B, Hoschke B, Gilfrich C, Wülfing C, Lang C, Wiesner C, Fahlenkamp D, Scheer D, Diefenbach G, Wechsel HW, Leyh H, Sperling H, Manka L, Grimm MO, Funk M, Wille S, Wöhr M, Rink M, Wustmann R, Olianas R, Steiner R, Flühr R, Machtens S, Vögele S, Klotz T
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
World J Urol. 2017;35(2): 245-250; May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A, Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May SD, PROMETRICS 2011 Research Group , Bartsch G, Bolenz C, Buchner A, Chun F, Dahlem R, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gördük M, Grimm M, Grimm T, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Janetschek G, Karl A, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Mayr R, Michel M, Moritz R, Müller S, Nuhn P, Pahernik S, Palisaar R, Ponholzer A, Protzel C, Pycha A, Rink M, Roghmann F, Roigas J, Schmid M, Schramek P, Seitz C, Shariat S, Sikic D, Syring I, Vallo S, Wagenlehner F, Wullich B
Bicentric prospective evaluation of corporoplasty with porcine small intestinal submucosa (SIS) in patients with severe Peyronie's disease
World J Urol. 2017;35(7): 1119-1124; Sayedahmed K, Rosenhammer B, Spachmann PJ, Burger M, Aragona M, Kaftan BT, Olianas R, Fritsche HM
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
World J Urol. 2017;35(3): 379-387; Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN
Do General Surgeons Feel Adequately Prepared for the Complex Questions Associated with the Handling of Multi-Resistant Pathogens? - Results of the MR2 Survey
Zentralbl Chir. 2017;142(3): 297-305; May M, Spachmann PJ, Lebentrau S, Schumacher H, Gilfrich C, Fritsche HM, Vetterlein M, Brookman-May S, Schostak M, Wagenlehner FM, Burger M, Novotny A, Obermaier R
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz(at)csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie(at)csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
